<i>MET</i> Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to CrizotinibJochen K. Lennerz, A. John Iafrate, Stephen B. Fox et al.|Journal of Clinical Oncology|2011Cited by 433
Epidemiology, Precursors, and Markers of Malignant MelanomaR.M. MACKIE, W. Bergman, A. B. Ackerman et al.|Unknown|1988Cited by 0